In some cases, PTHrP may not be directly involved in regulating 1,25-dihydroxyvitamin D levels, but its action on bones and kidneys is enough to cause hypercalcemia. Although PTHrP shares some similarities with PTH, such as the ability to increase blood calcium levels, they have important differences. Here, PTH is linked to hypercalcemia disease.